Cargando…
Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes
Intrinsic insulin secretion capacity may be preserved by discontinuing anti‐PD‐1 antibody treatment in ‘anti‐PD‐1 antibody‐induced‘fulminant type 1 diabetes.[Image: see text]
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835468/ https://www.ncbi.nlm.nih.gov/pubmed/29504279 http://dx.doi.org/10.1111/jdi.12662 |
| _version_ | 1783303819840454656 |
|---|---|
| author | Sakai, Gota Saito, Daigo Nakajima, Ritsuko Hatano, Masako Noguchi, Yuichi Kurihara, Susumu Katayama, Shigehiro Inoue, Ikuo Noda, Mitsuhiko Shimada, Akira |
| author_facet | Sakai, Gota Saito, Daigo Nakajima, Ritsuko Hatano, Masako Noguchi, Yuichi Kurihara, Susumu Katayama, Shigehiro Inoue, Ikuo Noda, Mitsuhiko Shimada, Akira |
| author_sort | Sakai, Gota |
| collection | PubMed |
| description | Intrinsic insulin secretion capacity may be preserved by discontinuing anti‐PD‐1 antibody treatment in ‘anti‐PD‐1 antibody‐induced‘fulminant type 1 diabetes.[Image: see text] |
| format | Online Article Text |
| id | pubmed-5835468 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58354682018-03-07 Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes Sakai, Gota Saito, Daigo Nakajima, Ritsuko Hatano, Masako Noguchi, Yuichi Kurihara, Susumu Katayama, Shigehiro Inoue, Ikuo Noda, Mitsuhiko Shimada, Akira J Diabetes Investig Letters to the Editor Intrinsic insulin secretion capacity may be preserved by discontinuing anti‐PD‐1 antibody treatment in ‘anti‐PD‐1 antibody‐induced‘fulminant type 1 diabetes.[Image: see text] John Wiley and Sons Inc. 2018-03-04 2018-03 /pmc/articles/PMC5835468/ /pubmed/29504279 http://dx.doi.org/10.1111/jdi.12662 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Sakai, Gota Saito, Daigo Nakajima, Ritsuko Hatano, Masako Noguchi, Yuichi Kurihara, Susumu Katayama, Shigehiro Inoue, Ikuo Noda, Mitsuhiko Shimada, Akira Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title | Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title_full | Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title_fullStr | Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title_full_unstemmed | Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title_short | Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| title_sort | intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835468/ https://www.ncbi.nlm.nih.gov/pubmed/29504279 http://dx.doi.org/10.1111/jdi.12662 |
| work_keys_str_mv | AT sakaigota intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT saitodaigo intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT nakajimaritsuko intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT hatanomasako intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT noguchiyuichi intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT kuriharasusumu intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT katayamashigehiro intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT inoueikuo intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT nodamitsuhiko intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes AT shimadaakira intrinsicinsulinsecretioncapacitymightbepreservedbydiscontinuingantiprogrammedcelldeathprotein1antibodytreatmentinantiprogrammedcelldeathprotein1antibodyinducedfulminanttype1diabetes |